Skip to main content

Table 3 Difference in protein expression between tumours from 5-year overall survivors and tumours from deceased patients

From: Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray

 

Dead patients

Alive patients

  

Protein

Protein expression positive (%)

Protein expression negative (%)

Protein expression positive (%)

Protein expression negative (%)

not available (No of samples)

P-value dead vs. alive patients

AdipoR1

26

74

17

83

3

0.29

Adora1

30

70

23

77

8

0.47

BTG2

61

39

82

18

6

0.026*

-membrane only

19

81

44

56

6

0.013*

-cytoplasm only

52

48

68

32

6

0.14

CD46

16

84

14

86

4

0.77

  1. P-values were calculated using a two-tailed Fisher's exact test. The samples designated as not available had few tumour cells, large tissue loss or affluence of necrotic tissue.